Page last updated: 2024-08-24

triazoles and bictegravir

triazoles has been researched along with bictegravir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Álvarez, H; Llibre, JM; Yzusqui, M1
Alves Saldanha, S; André, P; Buclin, T; Cavassini, M; Choong, E; Courlet, P; Csajka, C; Decosterd, LA; Desfontaine, V; Günthard, HF; Marzolini, C1
Cottrell, ML; Imaz, A; Kashuba, AD; Podzamczer, D; Schauer, AP; Sykes, C1

Reviews

1 review(s) available for triazoles and bictegravir

ArticleYear
Clinical Impact of Virological Failure and Resistance Analysis Definitions used in Pivotal Clinical Trials of Initial Antiretroviral Treatment: A Systematic Review
    AIDS reviews, 2018, Volume: 20, Issue:3

    Topics: Amides; Anti-Retroviral Agents; Clinical Trials as Topic; Cobicistat; Darunavir; Drug Resistance, Viral; Genotype; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Oxazines; Piperazines; Pyridones; Quinolones; Rilpivirine; RNA, Viral; Triazoles; Viral Load

2018

Other Studies

2 other study(ies) available for triazoles and bictegravir

ArticleYear
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HI
    Journal of mass spectrometry : JMS, 2020, Volume: 55, Issue:6

    Topics: Amides; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Limit of Detection; Linear Models; Piperazines; Pyridones; Reference Standards; Reproducibility of Results; Rilpivirine; Tandem Mass Spectrometry; Triazoles

2020
Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma.
    Journal of pharmaceutical and biomedical analysis, 2022, Oct-25, Volume: 220

    Topics: Amides; Chromatography, Liquid; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Piperazines; Pyridones; Raltegravir Potassium; Reproducibility of Results; Reverse Transcriptase Inhibitors; Tandem Mass Spectrometry; Triazoles

2022